Merck to Pay $5.9 Mln for Misleading Marketing of Pink Eye Drug: U.S.

Merck & Co Inc has agreed to pay $5.9 million to resolve claims that a former unit fraudulently promoted a drug used to treat pink eye for unapproved purposes, U.S. authorities announced on Wednesday.
Reuters Health Information

Full Story →